Dynamic factors controlling targeting nanocarriers to vascular endothelium.
暂无分享,去创建一个
Ravi Radhakrishnan | Vladimir R Muzykantov | V. Muzykantov | R. Radhakrishnan | D. Eckmann | David M Eckmann
[1] Vladimir Torchilin,et al. Multifunctional and stimuli-sensitive pharmaceutical nanocarriers. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[2] T. W. Secomb,et al. The endothelial surface layer , 2000, Pflügers Archiv.
[3] D. Hammer,et al. Characterization of biodegradable drug delivery vehicles with the adhesive properties of leukocytes. , 2002, Biomaterials.
[4] Mohammad F. Kiani,et al. Targeting Microparticles to Select Tissue via Radiation-Induced Upregulation of Endothelial Cell Adhesion Molecules , 2002, Pharmaceutical Research.
[5] Simon C Watkins,et al. Microbubbles targeted to intercellular adhesion molecule-1 bind to activated coronary artery endothelial cells. , 1998, Circulation.
[6] V. Muzykantov,et al. Slow intracellular trafficking of catalase nanoparticles targeted to ICAM-1 protects endothelial cells from oxidative stress. , 2003, American journal of physiology. Cell physiology.
[7] G. Molema. Tumor Vasculature Directed Drug Targeting: Applying New Technologies and Knowledge to the Development of Clinically Relevant Therapies , 2002, Pharmaceutical Research.
[8] H. Harashima,et al. Ligand-based targeted delivery of a peptide modified nanocarrier to endothelial cells in adipose tissue. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[9] A. Malik,et al. Signaling mechanisms regulating endothelial permeability. , 2006, Physiological reviews.
[10] A. Al-Mehdi,et al. Endothelial NADPH oxidase as the source of oxidants in lungs exposed to ischemia or high K+. , 1998, Circulation research.
[11] V. Muzykantov,et al. Targeting of antioxidant and anti-thrombotic drugs to endothelial cell adhesion molecules. , 2005, Current pharmaceutical design.
[12] H. Shmeeda,et al. Her2-targeted pegylated liposomal doxorubicin: retention of target-specific binding and cytotoxicity after in vivo passage. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[13] V. Labhasetwar,et al. Quantification of the force of nanoparticle-cell membrane interactions and its influence on intracellular trafficking of nanoparticles. , 2008, Biomaterials.
[14] D. Hammer,et al. Artificial polymeric cells for targeted drug delivery. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[15] A. Geist,et al. Protein dynamics and enzymatic catalysis: investigating the peptidyl-prolyl cis-trans isomerization activity of cyclophilin A. , 2004, Biochemistry.
[16] A. Al-Mehdi,et al. Simulated ischemia in flow-adapted endothelial cells leads to generation of reactive oxygen species and cell signaling. , 1999, Circulation research.
[17] Kandaswamy Vijayan,et al. Micelles of Different Morphologies—Advantages of Worm-like Filomicelles of PEO-PCL in Paclitaxel Delivery , 2007, Pharmaceutical Research.
[18] J Szebeni,et al. Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. , 2003, Progress in lipid research.
[19] A. Mulivor,et al. Role of glycocalyx in leukocyte-endothelial cell adhesion. , 2002, American journal of physiology. Heart and circulatory physiology.
[20] V. Muzykantov,et al. Targeted delivery of therapeutics to endothelium , 2008, Cell and Tissue Research.
[21] J. Loscalzo,et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. , 1998, Blood.
[22] E. Damiano. The effect of the endothelial-cell glycocalyx on the motion of red blood cells through capillaries. , 1998, Microvascular research.
[23] M Ferrari,et al. Size and shape effects in the biodistribution of intravascularly injected particles. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[24] S. Chien,et al. Activation of Rac1 by shear stress in endothelial cells mediates both cytoskeletal reorganization and effects on gene expression , 2002, The EMBO journal.
[25] M P Bevilacqua,et al. Endothelial-leukocyte adhesion molecules. , 1993, Annual review of immunology.
[26] H. Fusamoto,et al. Expression of ICAM-1 is involved in the mechanism of liver injury during liver transplantation: therapeutic usefulness of the F(ab')2 fragment of an anti-ICAM-1 monoclonal antibody. , 1996, Transplantation proceedings.
[27] J. Stoltz,et al. Shear stress induces caveolin-1 translocation in cultured endothelial cells , 2002, European Biophysics Journal.
[28] W. Jefferies,et al. Transferrin receptor on endothelium of brain capillaries , 1984, Nature.
[29] M Ferrari,et al. Flow chamber analysis of size effects in the adhesion of spherical particles , 2007, International journal of nanomedicine.
[30] V. Muzykantov,et al. Optimizing endothelial targeting by modulating the antibody density and particle concentration of anti-ICAM coated carriers. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[31] B. Duling,et al. Capillary endothelial surface layer selectively reduces plasma solute distribution volume. , 2000, American journal of physiology. Heart and circulatory physiology.
[32] P. Davies,et al. Flow-mediated endothelial mechanotransduction. , 1995, Physiological reviews.
[33] V. Muzykantov,et al. Endothelial targeting of a recombinant construct fusing a PECAM-1 single-chain variable antibody fragment (scFv) with prourokinase facilitates prophylactic thrombolysis in the pulmonary vasculature. , 2005, Blood.
[34] L. Glimcher,et al. Differing regulation and function of ICAM-1 and class II antigens on renal tubular cells. , 1990, Kidney international.
[35] Samir Mitragotri,et al. Flow and adhesion of drug carriers in blood vessels depend on their shape: a study using model synthetic microvascular networks. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[36] Silvia Muro,et al. Flow dynamics, binding and detachment of spherical carriers targeted to ICAM-1 on endothelial cells. , 2009, Biorheology.
[37] A. Gotlieb,et al. Patterns of Endothelial Microfilament Distribution in the Rabbit Aorta In Situ , 1989, Circulation research.
[38] Jacob Klein,et al. Reduction of frictional forces between solid surfaces bearing polymer brushes , 1994, Nature.
[39] V. Labhasetwar,et al. Characterization of nanoparticle uptake by endothelial cells. , 2002, International journal of pharmaceutics.
[40] Sei-Young Lee,et al. Shaping nano-/micro-particles for enhanced vascular interaction in laminar flows , 2009, Nanotechnology.
[41] D. Hallahan,et al. Intercellular adhesion molecule 1 knockout abrogates radiation induced pulmonary inflammation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[42] Molly S. Shoichet,et al. Tunable immunonanoparticle binding to cancer cells: thermodynamic analysis of targeted drug delivery vehicles , 2009 .
[43] Aliasger K Salem,et al. Leukocyte-inspired biodegradable particles that selectively and avidly adhere to inflamed endothelium in vitro and in vivo , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[44] G. Bendas,et al. VCAM-1 directed immunoliposomes selectively target tumor vasculature in vivo. , 2008, Biochimica et biophysica acta.
[45] Alexander V Kabanov,et al. Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery. , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[46] S. Kennel,et al. Vascular immunotargeting of glucose oxidase to the endothelial antigens induces distinct forms of oxidant acute lung injury: targeting to thrombomodulin, but not to PECAM-1, causes pulmonary thrombosis and neutrophil transmigration. , 2002, The American journal of pathology.
[47] Phapanin Charoenphol,et al. Potential role of size and hemodynamics in the efficacy of vascular-targeted spherical drug carriers. , 2010, Biomaterials.
[48] Mauro Ferrari,et al. Intravascular Delivery of Particulate Systems: Does Geometry Really Matter? , 2008, Pharmaceutical Research.
[49] R. Duncan. Polymer-Drug Conjugates: Targeting Cancer , 2002 .
[50] D. Hammer,et al. Interplay between rolling and firm adhesion elucidated with a cell-free system engineered with two distinct receptor-ligand pairs. , 2003, Biophysical journal.
[51] P. Agarwal,et al. Network of coupled promoting motions in enzyme catalysis , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[52] Silvia Muro,et al. Delivery of Acid Sphingomyelinase in Normal and Niemann-Pick Disease Mice Using Intercellular Adhesion Molecule-1-Targeted Polymer Nanocarriers , 2008, Journal of Pharmacology and Experimental Therapeutics.
[53] Samir Mitragotri,et al. Role of target geometry in phagocytosis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[54] D. Crommelin,et al. Adhesion molecules: a new target for immunoliposome‐mediated drug delivery , 1995, FEBS letters.
[55] Timothy A. Springer,et al. Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1) , 1987, Cell.
[56] Silvia Muro,et al. Endothelial Targeting of High-Affinity Multivalent Polymer Nanocarriers Directed to Intercellular Adhesion Molecule 1 , 2006, Journal of Pharmacology and Experimental Therapeutics.
[57] S. Milner. Hydrodynamic penetration into parabolic brushes , 1991 .
[58] M. Cybulsky,et al. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. , 1991, Science.
[59] Samir Mitragotri,et al. Particle shape: a new design parameter for micro- and nanoscale drug delivery carriers. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[60] P Bongrand,et al. Cell adhesion. Competition between nonspecific repulsion and specific bonding. , 1984, Biophysical journal.
[61] W. Pardridge. Molecular Trojan horses for blood-brain barrier drug delivery. , 2006, Discovery medicine.
[62] T. Annecke,et al. Therapeutic strategies targeting the endothelial glycocalyx: acute deficits, but great potential. , 2010, Cardiovascular research.
[63] M. Tavassoli,et al. Liver endothelium and not hepatocytes or Kupffer cells have transferrin receptors. , 1984, Blood.
[64] R M Heethaar,et al. Blood platelets are concentrated near the wall and red blood cells, in the center in flowing blood. , 1988, Arteriosclerosis.
[65] G. Grest. Normal and Shear Forces Between Polymer Brushes , 1999 .
[66] P. Vanhoutte. Endothelium-derived free radicals: for worse and for better. , 2001, The Journal of clinical investigation.
[67] C. Berkland,et al. ICAM-1 targeting of doxorubicin-loaded PLGA nanoparticles to lung epithelial cells. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[68] Alexander V Kabanov,et al. Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[69] Tamar Schlick,et al. Analysis of protein sequence/structure similarity relationships. , 2002, Biophysical journal.
[70] V. Muzykantov,et al. A novel endocytic pathway induced by clustering endothelial ICAM-1 or PECAM-1 , 2003, Journal of Cell Science.
[71] Doriano Brogioli,et al. Lipid-based nanoparticles with high binding affinity for amyloid-beta1-42 peptide. , 2010, Biomaterials.
[72] V. Muzykantov,et al. Synthetic Carriers for Vascular Delivery of Protein Therapeutics , 2006, Biotechnology & genetic engineering reviews.
[73] E. Ruoslahti,et al. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. , 1998, Science.
[74] V. Muzykantov,et al. Characterization of endothelial internalization and targeting of antibody-enzyme conjugates in cell cultures and in laboratory animals. , 2004, Methods in molecular biology.
[75] R. Thrall,et al. Early detection of oleic acid-induced lung injury in rats using (111)In-labeled anti-rat intercellular adhesion molecule-1. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[76] A. Klibanov,et al. Ligand-carrying gas-filled microbubbles: ultrasound contrast agents for targeted molecular imaging. , 2005, Bioconjugate chemistry.
[77] M. Simionescu,et al. Transcytosis of plasma macromolecules in endothelial cells: A cell biological survey , 2002, Microscopy research and technique.
[78] M Ferrari,et al. The receptor-mediated endocytosis of nonspherical particles. , 2008, Biophysical journal.
[79] V. Muzykantov,et al. Lysosomal enzyme delivery by ICAM-1-targeted nanocarriers bypassing glycosylation- and clathrin-dependent endocytosis. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.
[80] T. Minko,et al. Receptor targeted polymers, dendrimers, liposomes: which nanocarrier is the most efficient for tumor-specific treatment and imaging? , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[81] Ianessa Morantte,et al. Humanization of an anti-ICAM-1 antibody with over 50-fold affinity and functional improvement. , 2003, Journal of immunological methods.
[82] R. Radhakrishnan,et al. The Role of Glycocalyx in Nanocarrier-Cell Adhesion Investigated Using a Thermodynamic Model and Monte Carlo Simulations. , 2007, The journal of physical chemistry. C, Nanomaterials and interfaces.
[83] D. Buerk,et al. Immunotargeting of catalase to the pulmonary endothelium alleviates oxidative stress and reduces acute lung transplantation injury , 2003, Nature Biotechnology.
[84] O. McCarty,et al. Single Molecule Characterization of P-selectin/Ligand Binding* 210 , 2003, The Journal of Biological Chemistry.
[85] Mauro Ferrari,et al. Design maps for nanoparticles targeting the diseased microvasculature. , 2008, Biomaterials.
[86] Samir Mitragotri,et al. Role of Particle Size in Phagocytosis of Polymeric Microspheres , 2008, Pharmaceutical Research.
[87] Daniel A Hammer,et al. Selectin catch–slip kinetics encode shear threshold adhesive behavior of rolling leukocytes , 2008, Proceedings of the National Academy of Sciences.
[88] V. Muzykantov,et al. ICAM-1 recycling in endothelial cells: a novel pathway for sustained intracellular delivery and prolonged effects of drugs. , 2005, Blood.
[89] K. Burridge,et al. Leukocyte transendothelial migration: orchestrating the underlying molecular machinery. , 2001, Current opinion in cell biology.
[90] G. Johnson,et al. Ligand Regulates Epidermal Growth Factor Receptor Kinase Specificity , 2004, Journal of Biological Chemistry.
[91] A. Mulivor,et al. Inflammation- and ischemia-induced shedding of venular glycocalyx. , 2004, American journal of physiology. Heart and circulatory physiology.
[92] S. Weinbaum,et al. A hydrodynamic mechanosensory hypothesis for brush border microvilli. , 2000, American journal of physiology. Renal physiology.
[93] S M Moghimi,et al. Long-circulating and target-specific nanoparticles: theory to practice. , 2001, Pharmacological reviews.
[94] D. Altieri,et al. Apical topography and modulation of ICAM-1 expression on activated endothelium. , 1995, The American journal of pathology.
[95] Daniel A Hammer,et al. Quantifying nanoparticle adhesion mediated by specific molecular interactions. , 2008, Langmuir : the ACS journal of surfaces and colloids.
[96] Denis Wirtz,et al. Organization of Cellular Receptors into a Nanoscale Junction during HIV-1 Adhesion , 2010, PLoS Comput. Biol..
[97] V. Muzykantov,et al. Immunotargeting of catalase to ACE or ICAM-1 protects perfused rat lungs against oxidative stress. , 1998, American journal of physiology. Lung cellular and molecular physiology.
[98] L. Cipelletti,et al. Size-dependent intracellular immunotargeting of therapeutic cargoes into endothelial cells. , 2002, Blood.
[99] V. Torchilin,et al. p-Nitrophenylcarbonyl-PEG-PE-liposomes: fast and simple attachment of specific ligands, including monoclonal antibodies, to distal ends of PEG chains via p-nitrophenylcarbonyl groups. , 2001, Biochimica et biophysica acta.
[100] Samir Mitragotri,et al. Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.
[101] A. Beaudet,et al. Role of the intercellular adhesion molecule-1(ICAM-1) in endotoxin-induced pneumonia evaluated using ICAM-1 antisense oligonucleotides, anti-ICAM-1 monoclonal antibodies, and ICAM-1 mutant mice. , 1996, The Journal of clinical investigation.
[102] M. Cybulsky,et al. Immunotargeting of liposomes to activated vascular endothelial cells: a strategy for site-selective delivery in the cardiovascular system. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[103] Stephen C. Cowin,et al. Mechanotransduction and flow across the endothelial glycocalyx , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[104] G. I. Bell. Models for the specific adhesion of cells to cells. , 1978, Science.
[105] R. Rothlein,et al. Integrins, ICAMs, and selectins: role and regulation of adhesion molecules in neutrophil recruitment to inflammatory sites. , 1994, Advances in pharmacology.
[106] U. Welsch,et al. GLYCOCALYX PROTECTION REDUCES LEUKOCYTE ADHESION AFTER ISCHEMIA/REPERFUSION , 2010, Shock.
[107] Kenneth A. Dawson,et al. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts , 2008, Proceedings of the National Academy of Sciences.
[108] M. Gimbrone,et al. Vascular endothelium, hemodynamic forces, and atherogenesis. , 1999, The American journal of pathology.
[109] S. Santra,et al. Role of nanoparticle valency in the nondestructive magnetic-relaxation-mediated detection and magnetic isolation of cells in complex media. , 2009, Journal of the American Chemical Society.
[110] S. Izumo,et al. Fluid shear stress differentially modulates expression of genes encoding basic fibroblast growth factor and platelet-derived growth factor B chain in vascular endothelium. , 1993, The Journal of clinical investigation.
[111] D. Hammer,et al. I-domain of lymphocyte function-associated antigen-1 mediates rolling of polystyrene particles on ICAM-1 under flow. , 2005, Biophysical journal.
[112] Daniel A Hammer,et al. The state diagram for cell adhesion mediated by two receptors. , 2003, Biophysical journal.
[113] S. Santra,et al. Emerging nanotechnology-based strategies for the identification of microbial pathogenesis. , 2010, Advanced drug delivery reviews.
[114] V. Muzykantov. Immunotargeting of drugs to the pulmonary vascular endothelium as a therapeutic strategy , 1998 .
[115] G. Whitesides. The 'right' size in nanobiotechnology , 2003, Nature Biotechnology.